Enbiosis is a London-based biotechnology company that develops Digital Twin & AI-powered, clinically validated nutraceutical formulations targeting the gut microbiome.
Unlike trial-and-error supplements or pharmaceuticals with heavy side effects, Enbiosis uses Digital Twin and AI to design clinically validated, food-grade formulations that address the root cause.
The gut microbiome is a community of trillions of microorganisms in the digestive system that influences metabolism, immune function, brain health, hormonal balance, and more.
The gut microbiome is one of the body’s most powerful regulatory systems. By targeting it, we can address health conditions across multiple body systems, from metabolic and brain health to immune function, skin, and eye health.
Yes. Diet, lifestyle, environment, and genetics all shape the gut microbiome differently across regions and populations. This means an ingredient that works well in one population may produce different results in another.
Enbiosis uses computational modelling to account for this variability, designing formulations that work across diverse microbiome profiles rather than a single population average.
Our AI platform runs simulations across thousands of real human microbiome profiles to identify what the gut needs to produce for a specific health condition, then works backwards to find the right food-grade ingredients.
An AI-powered tool that works backwards from a target metabolite to identify the minimal set of food-grade ingredients that gut bacteria can naturally convert into the required compounds.
A digital twin is a virtual model of the gut microbiome. Before we select a single ingredient, we run thousands of simulations inside this model to understand how different combinations will behave in the gut. This means every formulation we design has been tested computationally before it is tested clinically.
Yes. A completed pilot study on eye health showed a 60.7% improvement in ocular surface outcomes and a +6.03 mm improvement in tear production. Improvements were sustained even after the intervention ended. A randomised, double-blind, placebo-controlled trial is currently ongoing.
Enbiosis is conducting clinical studies across multiple health areas, including eye, gastrointestinal, metabolic, urological, dermatological, hormonal, and neurological health.
Enbiosis supports gut microbiome pathways across a broad range of health areas, including metabolic, cognitive and mental, neurological, immune, cardiovascular, skin, and autoimmune, as well as wellness goals such as eye health, longevity, oral health, and hormonal balance.
Enbiosis formulations support gut microbiome pathways associated with specific health areas. They are not intended to diagnose, treat, cure, or prevent any disease. Please consult a healthcare professional for personal health concerns.
Enbiosis supports gut microbiome pathways across Metabolic, Cognitive & Mental Health, Neurological, Immune, and Oncology areas, as well as wellness goals including eye health, skin, longevity, oral health, and hormonal balance.
Enbiosis has developed a clinically validated formulation targeting gut microbiome pathways associated with eye health and ocular surface health through the gut-eye axis.
Enbiosis has developed formulations targeting gut microbiome pathways associated with brain health and cognitive function the gut-brain axis. Clinical research in this area is ongoing.
Enbiosis has developed formulations targeting gut microbiome pathways associated with skin barrier function and hydration. Clinical research in this area is ongoing.
Enbiosis formulations are compatible with capsules & powders, dairy & fermented products, functional foods, and functional beverages (wellness drinks, metabolic shots). Format compatibility is evaluated per formulation.
Efficacy timelines vary depending on the formulation and health area. For detailed information, please visit enbiosis.com or contact our team directly.
Enbiosis is a formulation platform. Our blends vary from formulation to formulation, so we are unable to provide Vegan, Halal, or Kosher declarations for individual blends. These certifications are managed through our Licensing Partners. For more information, please visit enbiosis.com or contact our team directly.
Enbiosis’s technology is supported by multiple layers of scientific and regulatory validation. The platform has received the UK Tech Rocketship Award Gold, with research published in Q1 peer-reviewed journals. Formulations are built exclusively from EFSA and FDA permitted ingredients, manufactured to GMP standards, and supported by active patent applications.
